PRODUCTS
More Reyra operates in three business segments: active pharmaceutical ingredients (API), final formulations, and research and contract supply.
We collaborate with global pharmaceutical companies to produce complex and specialized fermentation- and semi-synthetic-based active pharmaceutical ingredients (APIs) in the fields of immunosuppressants, oncology, antibacterials, and antifungals.
At More Reyra, quality is our top priority. We adhere to a “one product-one process” philosophy for global markets, ensuring consistency and reliability. This approach underpins our global DMF filings. More Reyra is recognized as a trusted and reliable supplier of APIs that meet international regulatory standards.
Understanding and meeting customer needs within a specified timeframe is crucial to the success of More Reyra Trading Company. Over the years, More Reyra has successfully launched numerous products and maintains a strong and active production line, enabling us to effectively respond to market demands and deliver high-quality commercial products to our customers in a timely manner.
More Reyra has also developed and commercialized a portfolio of complex and challenging formulations for global markets. The company sells its products in the USA and other international markets, offering oral solids (tablets and capsules), oral liquids, and suspensions across therapeutic segments such as Immunosuppressants, Nephrology drugs, and critical care Anti-infectives.
Leveraging its core capabilities in fermentation- and semi-synthetic-based active pharmaceutical ingredients (APIs), along with the development of complex formulations, More Reyra Trading Company offers comprehensive services from conceptualization to commercialization as part of its research and contract supply business. Currently, More Reyra is working on several new chemical entities (NCEs) and generic products, with a primary focus on strain improvement, media optimization, scaling processes from research and development to pilot and commercial stages, and the development of complex formulations. This approach enables us to effectively meet customer needs and deliver high-quality commercial products to global markets.
API
Research and Contract Supply
PRODUCTS
More Reyra provides research and contract supply services, specializing in fermentation processes and the preparation of semi-synthetic new chemical entities (NCEs) and small molecules.
More Reyra boasts one of the world’s most extensive portfolios of complex fermentation and semi-synthetic APIs.
FORMULATION
Research and Contract Development
EMERGING MERKETS
REGULATED MARKETS
INDIA FORMULATION
NEPHROLOGY
CRITICAL CARE
More Reyra Trading Company is a fully integrated company that develops immunosuppressant formulations and supplies products related to chronic kidney disease and nephrology under its own brand.
More Reyra is dedicated to delivering high-quality products in the Critical Care segment with a patient-centric approach aimed at saving lives.